Support the Australian Innovation & Manufacturing Incentive
AusBiotech is advocating for the Australian Innovation and Manufacturing (AIM) Incentive as an amendment to the current Australian corporate tax regime and seeks case study examples of Australian businesses that would benefit from such an amendment.
The AIM Incentive would provide a reduction in the tax payable on any profits derived from the commercialisation of qualifying IP in Australia (either via licensing or manufacturing and sale of products incorporating qualifying IP), with the purpose of making the commercialisation of IP and manufacturing in Australia more viable.
To support AusBiotech in making the case for the AIM Incentive to be enacted in law, we are seeking assistance. If you are an Australian company that is supportive of the Australian innovation and manufacturing and want to support the advocacy to the government as a case study, please email Lorraine Chiroiu at lchiroiu@ausbiotech.org for a case study form.
If you would like to know more about the AIM Incentive, please click here to read the policy document.
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
